AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
Gary Beale(Epistem (United Kingdom)), Helen L. Reeves(Newcastle upon Tyne Hospital), Paolo Trerotoli(University of Bari Aldo Moro), Derek Manas, Gianluigi Giannelli(Gastroenterology Hospital "Saverio de Bellis"), Dipankar Chattopadhyay(University of Calcutta), Stephen Stewart(Freeman Hospital), Mark Hudson(The Open University), Christopher P. Day(Newcastle University), Joe W. Gray(University of Newcastle Australia)
Cited by 125
Related Papers
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
|Nature Genetics|2009|1.1k
Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
|Diabetes Care|2007|989
Role of epithelial to mesenchymal transition in hepatocellular carcinoma
|Journal of Hepatology|2016|641
The Human Tumor Atlas Network: Charting Tumor Transitions across Space and Time at Single-Cell Resolution
|Cell|2020|602
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
|Journal of Clinical Investigation|2012|591